spacer
large
spacer
large
spacer
small
Historic
medicines
100px
spacer
large
spacer
small
Medicine
16px
Condition
16px
CertuitAD®
16px
Neuroscience
16px
CertuitAD® was a lab-developed test (LDT) of Eli Lilly Clinical Diagnostics Laboratory, LLC (ELCDL), a wholly owned subsidiary of Eli Lilly and Company.
16px
CertuitAD® was for the detection of plasma P-tau217 and was intended to be used in patients aged 60 years and older presenting with cognitive impairment and being evaluated for Alzheimer's disease (AD) and other causes of cognitive decline.
16px
Cymbalta® (duloxetine delayed-release capsules)
16px
Neuroscience
16px
16px
16px
Effient® (prasugrel)
16px
Cardiovascular
16px
Effient® is no longer owned by Eli Lilly and Company in the U.S.*
16px
*Other company and product names are trademarks of their respective owners.
16px
Evista® (raloxifene hydrochloride)
16px
Bone muscle joint
16px
16px
16px
Gemzar (gemcitabine for injection)
16px
Cancer
16px
Gemzar withdrawn from FDA
16px
Glucagon™ (glucagon for injection)
16px
Diabetes
16px
Glucagon withdrawn from FDA
16px
Symbyax® (olanzapine and
fluoxetine)
16px
Neuroscience
16px
16px
16px
Zyprexa® / Zyprexa®
IntraMuscular / Zyprexa®
Zydis® (olanzapine)
16px
Neuroscience
16px
Zyprexa®, Zyprexa® Intramuscular and Zyprexa® Zydis® are no longer owned by Eli Lilly and Company in the US.
16px
16px
spacer
large
spacer
large